author-photo

Malcolm K. Brenner

Center for Cell and Gene Therapy
Houston Methodist Hospital
Baylor College of Medicine

781

Papers

40871

Citations

Citation Trend

Filter By

Papers (781) Sort By

Journal Conference Others

Improving the safety of iPSC-derived T cell therapy

2022
Show All
- Source
- Cite
- Save
Citations (0)
Taking T-Cell Oncotherapy Off-the-Shelf

2021 Trends in Immunology
Show All
- Source
- Cite
- Save
Citations (3)
Evidence generation and reproducibility in cell and gene therapy research: A call to action.

2021 Molecular therapy. Methods & clinical development
Show All
- Source
- Cite
- Save
Citations (1)
Reversal of exhaustion in engineered T cells.

2021 Science
- Maksim Mamonkin
- Malcolm K. Brenner
Show All
- Source
- Cite
- Save
Citations (1)
Early Signals of Anti-Tumor Efficacy and Safety with Autologous CD5.CAR T-Cells in Patients with Refractory/Relapsed T-Cell Lymphoma

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Safety and Efficacy of Off-the-Shelf CD30.CAR-Modified Epstein-Barr Virus-Specific T Cells in Patients with CD30-Positive Lymphoma

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity.

2021 Molecular Therapy
Show All
- Source
- Cite
- Save
Citations (4)
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors.

2021
Show All
- Source
- Cite
- Save
Citations (3)